KNOWLEDGE BANK

Interviews

Mitochondrial “swap” in the Tumor Microenvironment

Professor, Okayama University
Yosuke Togashi MD PhD is a Professor at Okayama University specializing in tumor microenvironment research He trained in respiratory medicine earned his PhD in genome biology and began cancer immunology research in

Articles

The Use of AI in Pharmacovigilance

Regulatory authorities RAs across the world are showing increased interest in the use and applications of artificial intelligence AI in pharmacovigilance PV At the same time these new cognitive technologies have generated concerns in the regulatory space public health and the life sciences industry RAs from different regions are focusing their efforts on developing standards and good practices for...

Research Insights

Knowledge integration using product R&D outsourcing in biotechnology

Abstract We build on systems integration literature to explain how and why knowledge integration of nonmodular products is based on a strategic choice between internalizing and outsourcing core RD The underresearched choice of outsourcing core RD on an ongoing basis appears to face risks of higher transactions costs and loss of control We illumina

Case Studies

Local Production Of Pharmaceuticals And Related Technology Transfer In Developing Countries

Abstract As stakeholders in the Global Strategy and Plan of Action on Public Health Innovation and Intellectual Property GSPAPHI adopted by the World Health Assembly in the United Nations Conference on Trade and Development UNCTAD the World Health Organization WHO and the International Centre for Trade and Sustainable Development ICTSD are col

Techno Trends

A 3D-Printed Clinical Device Intended to Detect Biomarkers of Preterm Birth

The DPrinted device is a microchip electrophoresis device that can sensitively detect three serum biomarkers of Preterm birth PTB

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

The Regulatory Landscape for Nutraceuticals

Suresh Garg

Suresh Garg is the CMD and Founder of Zeon Life Sciences. He has over 30 years of extensive experience in the fields of nutrition, dairy products, healthcare, and nutraceuticals. Under his leadership, Zeon has become a pioneer in contract manufacturing for nutraceuticals and herbal goods. Owing to his passion and ability to thrive in a variety of sociocultural environments, Zeon has entered international markets.

 

2

Tiny Vesicles, Big Impact

Disha Marwaha

Dr. Disha Marwaha received her PhD in biological sciences from CSIR-Central Drug Research Institute (CSIR-CDRI), India in 2024. She is currently an Assistant Professor at the GLA University, Mathura. She has more than 20 publications in international peer-reviewed Journals. She is an expert in formulation and development, nanomedicine and pharmacokinetics focusing on innovative therapeutic and targeted drug delivery systems.

Neha Singh

Dr. Neha Singh received her Ph.D. in Biological Sciences from the CSIR-Central Drug Research Institute (CSIR-CDRI), India, in 2025. She is currently an Assistant Professor at the Lloyd School of Pharmacy, Greater Noida. Dr. Singh has contributed extensively to the field of pharmaceutical sciences, with many publications, patents, and book chapters in internationally recognised peer-reviewed journals. Her primary research interests include formulation development, nanomedicine and pharmacokinetics, with a focus on innovative therapeutic strategies and targeted drug delivery systems. Dr. Singh’s work reflects her commitment to advancing precision medicine and developing next-generation solutions for healthcare.

3

Government Investment in AI Capabilities will Cement Singapore’s Position as a Premier Clinical Trial Location

Edwin Ng

Edwin Ng joined Medidata in 2014 and heads the Life Science industry of Dassault Systemes across the Asia Pacific region. Under his leadership, the company’s regional business recorded significant year-on-year growth and achieved multiple leadership awards. Edwin has spent the last 27 years of his career managing enterprise solutions businesses.

 

4

Therapeutic Peptides

Rienzi Mosqueda

Rienzi Mosqueda is a dedicated writer specialising in life science, health, and pharma content. With a passion for clear, engaging writing, Rienzi provides fresh perspectives on each topic. His ability to simplify complex ideas makes the articles valuable for readers of all backgrounds. As an emerging voice, Rienzi Mosqueda is committed to sharing knowledge and sparking discussions through their impactful writing.

 

5

Nanomedicine

Vinoth-Kumar Lakshmanan

Vinoth-Kumar Lakshmanan is a Senior Investigator and Professor for Prostate Cancer Biomarker Laboratory, Faculty of Clinical Research at Sri Ramachandra Institute of Higher Education and Research (DU), India and Adjunct Professor of Faculty of Engineering and Architectural Science, Toronto Metropolitan University, Canada. Vinoth has 20+ years’ experience in cancer biology. Scientific H Index 33 achieved with 4500 plus citations. He obtained Ph.D from University of Strasbourg, France, Post Doctoral from University of Regensburg and Karlsruhe Institute of Technology (KIT), Germany.

press releasesRead more...

Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

The Ministry of Health Labour and Welfare in Japan has granted approval for Sarclisa isatuximab subcutaneous SC formulation in combination with approved standardofcare regimens for the treatment of multiple myeloma

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Incyte Biosciences Japan GK today announced that Japans Ministry of Health Labour and Welfare MHLW has approved Minjuvi tafasitamab in combination with lenalidomide for the treatment of adults

Samsung Bioepis and Organon Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada

Samsung Bioepis and Organon a global healthcare company with a deep expertise in biosimilars announced the expansion of their development and commercialization agreement whereby Organon will obtain commercialization

Chai Discovery Collaborates with Lilly TuneLab to Offer AI Capabilities to Select Biotechs

Chai Discovery the AI company engineering models to discover new molecules today announced that certain Chai Discovery frontier AI model capabilities will be made available to companies participating in the Lilly TuneLab platform

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Charles River Laboratories International Inc NYSE CRL announced a collaboration with Lilly TuneLab a collaborative AIML drug discovery platform created by Eli Lilly and Company Lilly

Cold Chain Technologies Launches CCT Rx Secure to Streamline Specialty Pharmacy Shipments

Cold Chain Technologies has launched CCT Rx Secure a new digital application designed to support specialty pharmacies in making more informed repeatable packout decisions for temperaturesensitive shipments

EventsRead more...

23 - 24

Jun 2026

24 - 25

Jun 2026

6th Edition Drug Safety Symposium 2026

Courtyard by Marriott, Mumbai,...

25 - 26

Jun 2026

07 - 09

Jul 2026

The Pharma India Expo 2026

Bombay Exhibition Centre, Mumb...

07 - 09

Jul 2026

08 - 10

Jul 2026

CPHI SEA 2026

QSNCC, Bangkok, Thailand

09 - 11

Jul 2026

Pharma Pro&Pack Expo 2026

HITEX Exhibition Centre, Hyder...

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

LATEST NEWSRead more...

Greenstone Biosciences and Intel Partner to Advance AI-Driven Drug Discovery

Greenstone Biosciences Inc has entered into a strategic collaboration with Intel Corporation to accelerate AIenabled drug discovery by combining Greenstones largescale human induced pluripotent stem cell iPSC biobank with Intels advanced AI and computing infrastructure

SK pharmteco Partners with OTXL to Advance Rare Disease Therapies

SK pharmteco has entered into a strategic collaboration with the Orphan Therapeutics Accelerator OTXL to support the development and manufacturing of treatments for rare diseases

Boltz Collaborates with Takeda to Expand Use of Biomolecular AI Models in Drug Discovery

Boltz PBC has announced a collaboration with Takeda to deploy its advanced biomolecular artificial intelligence models and platform across Takedas research organisation

Insilico Reaches First Clinical Milestone for AI-Developed NLRP3 Inhibitor ISM8969

Insilico Medicine has completed firstinhuman dosing in the Phase I clinical study of ISM marking the first clinical milestone in its codevelopment partnership with Hygtia Therapeutics ISM is an orally administered

Biogen to Acquire RayThera to Strengthen Immunology Pipeline

Biogen has entered into a definitive agreement to acquire RayThera Inc a privately held biotechnology company focused on developing smallmolecule therapies for immunological diseases The deal is valued at up to billion

Jazz Pharmaceuticals and AbCellera Partner to Develop Next-Generation T-Cell Engaging Antibodies for Cancer

Jazz Pharmaceuticals and AbCellera have entered into a preclinical research collaboration option and licence agreement to discover and develop nextgeneration Tcell engaging TCE multispecific antibodies for gastrointestinal GI cancers and other solid tumours